FDA applicant
Trisalus Life Sciences
FDA records 4 decisions for Trisalus Life Sciences (Westminster, CO) from 2019 to 2026: 4 510(k) clearances. Most are in product codes KRA (Catheter, Continuous Flush) and DQY (Catheter, Percutaneous). Since 2016 its 510(k)s took a median of 27 days from receipt to decision, against 124 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 1 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Trisalus Life Sciences’s devices, and how often a recall has named them.
FDA decisions per year
2in 2023
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2019.
Planning a device like Trisalus Life Sciences’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report